Your browser doesn't support javascript.
loading
Diffuse Alveolar Hemorrhage Caused by Warfarin after Rifampicin Discontinuation.
Kiyota, Takashige; Shiota, Seiji; Hamanaka, Ryosuke; Tsutsumi, Daisuke; Takakura, Takeshi; Miyazaki, Eishi.
Afiliación
  • Kiyota T; Department of General Medicine, Almeida Memorial Hospital, Oita 870-1195, Japan.
  • Shiota S; Department of General Medicine, Almeida Memorial Hospital, Oita 870-1195, Japan.
  • Hamanaka R; Department of General Medicine, Almeida Memorial Hospital, Oita 870-1195, Japan.
  • Tsutsumi D; Department of General Medicine, Almeida Memorial Hospital, Oita 870-1195, Japan.
  • Takakura T; Department of General Medicine, Almeida Memorial Hospital, Oita 870-1195, Japan.
  • Miyazaki E; Department of General Medicine, Oita University Faculty of Medicine, Yufu 879-5593, Japan.
Case Rep Med ; 2019: 4917856, 2019.
Article en En | MEDLINE | ID: mdl-30809261
ABSTRACT
An 83-year-old man under warfarin therapy presented for assessment of prolonged prothrombin time and cough. High-resolution computed tomography findings of the chest showed diffuse alveolar hemorrhage. His international normalized ratio (INR) was 11.89. He had been treated with rifampicin for a persistent infection, but this had been discontinued about two months before admission. Rifampicin suppresses the anticoagulant activity of warfarin, which can lead to a need for increased doses of warfarin to achieve and maintain a therapeutic INR. More frequent INR monitoring is needed even after discontinuing rifampicin.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Case Rep Med Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Case Rep Med Año: 2019 Tipo del documento: Article